Skip to content

A clinical survey of atopic dermatitis patients.

A clinical survey of atopic dermatitis patients. - A clinical survey of atopic dermatitis patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025941
Enrollment
45
Registered
2017-02-18
Start date
2017-02-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

None listed

Sponsors

Shiba Palace Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Inclusion criteria of healthy subjects 1) healthy subjects 2) Subjects who agree with the joining this study based on the consent by the document B) Inclusion criteria of atopic dermatitis patients 1) Patients with atopic dermatitis 2) Patients with mild or moderate rash on the forearm and the cubital fossa 3) Patients who use topical steroid on both arms 4) Patients with narrow area of rash on the hands 5) Patients who agree with the joining this study based on the consent by the document

Exclusion criteria

Exclusion criteria: A. Exclusion criteria of healthy subjects 1) Subjects with allergic disease such as asthma and atopic dermatitis 2) Subjects with any complications which affect the results of this study 3) Subjects with difficulty of blood collection 4) Subjects with smoking habit 5) Subjects with severe sunburn on both arms 6) Subjects deemed inappropriate to participate in this study by the principal investigator or the sub-investigators B. Exclusion criteria of atopic dermatitis patients 1) Patients who use oral steroid 2) Subjects with allergic disease such as asthma 3) Patients with any complications which affect the results of this study 4) Patients with difficulty of blood collection 5) Patients with smoking habit 6) Patients with severe sunburn on both arms 7) Patients deemed inappropriate to participate in this study by the principal investigator or the sub-investigators

Design outcomes

Primary

MeasureTime frame
Instrument measurement values (Transepidermal water loss, water content of the stratum corneum, erythema and pigmentation, etc.)

Secondary

MeasureTime frame
Questionnaires for QOL assessment

Countries

Japan

Contacts

Public ContactReiko Maruya

SOUKEN CO., LTD clinical laboratory management

r_maruya@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026